{"transactions":[{"id":4619507,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-16T20:30:47.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":145.29,"value":435870.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":164096,"source":{"system":"sec-edgar","filing":"0001310204-26-000029","document":"wk-form4_1789590643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1310204/000131020426000029/wk-form4_1789590643.xml","form_type":"4"}},{"id":4616431,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-09-11T22:30:45.000Z","date":"2026-09-10","kind":"exercise","planned":false,"acquired":false,"shares":2797,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":25054,"derivative":{"underlying":"Common Stock","underlying_shares":2797},"source":{"system":"sec-edgar","filing":"0001310204-26-000027","document":"wk-form4_1789165843.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1310204/000131020426000027/wk-form4_1789165843.xml","form_type":"4"}},{"id":4616430,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-11T22:30:45.000Z","date":"2026-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1347,"price":144.81,"value":195059.07,"ownership":{"direct":true},"balance_after":167096,"source":{"system":"sec-edgar","filing":"0001310204-26-000027","document":"wk-form4_1789165843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1310204/000131020426000027/wk-form4_1789165843.xml","form_type":"4"}},{"id":4616429,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-11T22:30:45.000Z","date":"2026-09-10","kind":"exercise","planned":false,"acquired":true,"shares":2797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":168443,"source":{"system":"sec-edgar","filing":"0001310204-26-000027","document":"wk-form4_1789165843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1310204/000131020426000027/wk-form4_1789165843.xml","form_type":"4"}},{"id":306211,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-18T23:06:08.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":138.36,"value":415080.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":165646,"source":{"system":"sec-edgar","filing":"0001310204-26-000024","document":"wk-form4_1787094366.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000024/wk-form4_1787094366.xml","form_type":"4"}},{"id":307155,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-16T22:08:03.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":129.9256,"value":389776.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $129.45 to $130.08. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":168646,"source":{"system":"sec-edgar","filing":"0001310204-26-000022","document":"wk-form4_1784239680.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000022/wk-form4_1784239680.xml","form_type":"4"}},{"id":308240,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-16T21:53:26.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":125.4,"value":376200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":171646,"source":{"system":"sec-edgar","filing":"0001310204-26-000020","document":"wk-form4_1781646803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000020/wk-form4_1781646803.xml","form_type":"4"}},{"id":308408,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-06-11T22:32:47.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":false,"shares":2796,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":27851,"derivative":{"underlying":"Common Stock","underlying_shares":2796},"source":{"system":"sec-edgar","filing":"0001310204-26-000018","document":"wk-form4_1781217163.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000018/wk-form4_1781217163.xml","form_type":"4"}},{"id":308407,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-11T22:32:47.000Z","date":"2026-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1341,"price":121.48,"value":162904.68,"ownership":{"direct":true},"balance_after":174646,"source":{"system":"sec-edgar","filing":"0001310204-26-000018","document":"wk-form4_1781217163.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000018/wk-form4_1781217163.xml","form_type":"4"}},{"id":308406,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-11T22:32:47.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":true,"shares":2796,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":175987,"source":{"system":"sec-edgar","filing":"0001310204-26-000018","document":"wk-form4_1781217163.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000018/wk-form4_1781217163.xml","form_type":"4"}},{"id":309553,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-18T21:50:30.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":132.27,"value":396810.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":173191,"source":{"system":"sec-edgar","filing":"0001310204-26-000016","document":"wk-form4_1779141028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000016/wk-form4_1779141028.xml","form_type":"4"}},{"id":310690,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-16T22:41:54.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":140.96,"value":422880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":176191,"source":{"system":"sec-edgar","filing":"0001310204-26-000014","document":"wk-form4_1776379311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000014/wk-form4_1776379311.xml","form_type":"4"}},{"id":311542,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-17T22:14:00.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":144.23,"value":432690.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":179191,"source":{"system":"sec-edgar","filing":"0001310204-26-000012","document":"wk-form4_1773785637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000012/wk-form4_1773785637.xml","form_type":"4"}},{"id":311797,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-03-12T20:45:40.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":35880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options have a four-year vesting schedule. 25% vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":35880,"derivative":{"exercise_price":148.56,"expiration_date":"2036-03-10","underlying":"Common Stock","underlying_shares":35880},"source":{"system":"sec-edgar","filing":"0001310204-26-000010","document":"wk-form4_1773348337.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000010/wk-form4_1773348337.xml","form_type":"4"}},{"id":311796,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-12T20:45:40.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":9590,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":30647,"derivative":{"underlying":"Common Stock","underlying_shares":9590},"source":{"system":"sec-edgar","filing":"0001310204-26-000010","document":"wk-form4_1773348337.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000010/wk-form4_1773348337.xml","form_type":"4"}},{"id":311795,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-12T20:45:40.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":false,"shares":6469,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":21057,"derivative":{"underlying":"Common Stock","underlying_shares":6469},"source":{"system":"sec-edgar","filing":"0001310204-26-000010","document":"wk-form4_1773348337.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000010/wk-form4_1773348337.xml","form_type":"4"}},{"id":311794,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-12T20:45:40.000Z","date":"2026-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3147,"price":148.56,"value":467518.32,"ownership":{"direct":true},"balance_after":182191,"source":{"system":"sec-edgar","filing":"0001310204-26-000010","document":"wk-form4_1773348337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000010/wk-form4_1773348337.xml","form_type":"4"}},{"id":311793,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-12T20:45:40.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":true,"shares":6469,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":185338,"source":{"system":"sec-edgar","filing":"0001310204-26-000010","document":"wk-form4_1773348337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000010/wk-form4_1773348337.xml","form_type":"4"}},{"id":312417,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-02T21:57:32.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":11090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2025. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors."}],"balance_after":178869,"source":{"system":"sec-edgar","filing":"0001310204-26-000008","document":"wk-form4_1772488649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000008/wk-form4_1772488649.xml","form_type":"4"}},{"id":313402,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T22:11:41.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":154.43,"value":463290.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan."}],"balance_after":167779,"source":{"system":"sec-edgar","filing":"0001310204-26-000006","document":"wk-form4_1771452697.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000006/wk-form4_1771452697.xml","form_type":"4"}},{"id":314377,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-05T23:49:59.000Z","date":"2026-02-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":24802,"price":143.28,"value":3553630.56,"ownership":{"direct":true},"balance_after":170568,"source":{"system":"sec-edgar","filing":"0001310204-26-000004","document":"wk-form4_1770335396.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000004/wk-form4_1770335396.xml","form_type":"4"}},{"id":314376,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-05T23:49:59.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":44867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2023 and March 10, 2024. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares certified for grants made March 10, 2024 will not be issued to the Reporting Person until the requisite continuing service requirements are also met."}],"balance_after":195370,"source":{"system":"sec-edgar","filing":"0001310204-26-000004","document":"wk-form4_1770335396.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000004/wk-form4_1770335396.xml","form_type":"4"}},{"id":315276,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-16T23:18:22.000Z","date":"2026-01-15","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":124.31,"value":372930.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":150503,"source":{"system":"sec-edgar","filing":"0001310204-26-000002","document":"wk-form4_1768605499.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000002/wk-form4_1768605499.xml","form_type":"4"}},{"id":316122,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-16T23:31:59.000Z","date":"2025-12-15","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":122,"value":366000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":153503,"source":{"system":"sec-edgar","filing":"0001310204-25-000021","document":"wk-form4_1765927916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020425000021/wk-form4_1765927916.xml","form_type":"4"}},{"id":316260,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-12-12T01:40:00.000Z","date":"2025-12-10","kind":"exercise","planned":false,"acquired":false,"shares":3693,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":27526,"derivative":{"underlying":"Common Stock","underlying_shares":3693},"source":{"system":"sec-edgar","filing":"0001310204-25-000019","document":"wk-form4_1765503597.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020425000019/wk-form4_1765503597.xml","form_type":"4"}},{"id":316259,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-12T01:40:00.000Z","date":"2025-12-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1745,"price":121.34,"value":211738.3,"ownership":{"direct":true},"balance_after":156503,"source":{"system":"sec-edgar","filing":"0001310204-25-000019","document":"wk-form4_1765503597.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020425000019/wk-form4_1765503597.xml","form_type":"4"}},{"id":316258,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-12T01:40:00.000Z","date":"2025-12-10","kind":"exercise","planned":false,"acquired":true,"shares":3693,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":158248,"source":{"system":"sec-edgar","filing":"0001310204-25-000019","document":"wk-form4_1765503597.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020425000019/wk-form4_1765503597.xml","form_type":"4"}},{"id":317038,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-19T00:00:07.000Z","date":"2025-11-17","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":125.23,"value":313075.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":154555,"source":{"system":"sec-edgar","filing":"0001310204-25-000017","document":"wk-form4_1763510402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020425000017/wk-form4_1763510402.xml","form_type":"4"}},{"id":318017,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-17T01:35:03.000Z","date":"2025-10-15","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":118.08,"value":295200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":157055,"source":{"system":"sec-edgar","filing":"0001310204-25-000014","document":"wk-form4_1760664900.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020425000014/wk-form4_1760664900.xml","form_type":"4"}},{"id":318857,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-16T21:12:06.000Z","date":"2025-09-15","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":113.57,"value":283925.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in the this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":159555,"source":{"system":"sec-edgar","filing":"0001310204-25-000011","document":"wk-form4_1758057124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020425000011/wk-form4_1758057124.xml","form_type":"4"}},{"id":318910,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-09-11T22:28:40.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":false,"shares":3696,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule.  25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule.  25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":31219,"derivative":{"underlying":"Common Stock","underlying_shares":3696},"source":{"system":"sec-edgar","filing":"0001310204-25-000007","document":"wk-form4_1757629717.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020425000007/wk-form4_1757629717.xml","form_type":"4"}},{"id":318909,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-11T22:28:40.000Z","date":"2025-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1751,"price":115.25,"value":201802.75,"ownership":{"direct":true},"balance_after":162055,"source":{"system":"sec-edgar","filing":"0001310204-25-000007","document":"wk-form4_1757629717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020425000007/wk-form4_1757629717.xml","form_type":"4"}},{"id":318908,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-11T22:28:40.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":true,"shares":3696,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":163806,"source":{"system":"sec-edgar","filing":"0001310204-25-000007","document":"wk-form4_1757629717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020425000007/wk-form4_1757629717.xml","form_type":"4"}},{"id":319736,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-18T23:34:04.000Z","date":"2025-08-15","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":118.53,"value":296325.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":160110,"source":{"system":"sec-edgar","filing":"0001310204-25-000005","document":"wk-form4_1755560041.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020425000005/wk-form4_1755560041.xml","form_type":"4"}},{"id":320686,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-16T21:41:33.000Z","date":"2025-07-15","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":111.03,"value":277575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":162610,"source":{"system":"sec-edgar","filing":"0001127602-25-019286","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225019286/form4.xml","form_type":"4"}},{"id":321404,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-17T22:08:30.000Z","date":"2025-06-16","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":110.17,"value":275425.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":165110,"source":{"system":"sec-edgar","filing":"0001127602-25-017692","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225017692/form4.xml","form_type":"4"}},{"id":321527,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-06-11T22:52:40.000Z","date":"2025-06-10","kind":"exercise","planned":false,"acquired":false,"shares":3694,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":34915,"derivative":{"underlying":"Common Stock","underlying_shares":3694},"source":{"system":"sec-edgar","filing":"0001127602-25-017331","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225017331/form4.xml","form_type":"4"}},{"id":321526,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-11T22:52:40.000Z","date":"2025-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1758,"price":110.09,"value":193538.22,"ownership":{"direct":true},"balance_after":167610,"source":{"system":"sec-edgar","filing":"0001127602-25-017331","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225017331/form4.xml","form_type":"4"}},{"id":321525,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-11T22:52:40.000Z","date":"2025-06-10","kind":"exercise","planned":false,"acquired":true,"shares":3694,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":169368,"source":{"system":"sec-edgar","filing":"0001127602-25-017331","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225017331/form4.xml","form_type":"4"}},{"id":322192,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-16T20:34:29.000Z","date":"2025-05-15","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":99.82,"value":249550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":165674,"source":{"system":"sec-edgar","filing":"0001127602-25-014718","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225014718/form4.xml","form_type":"4"}},{"id":323146,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-16T19:22:20.000Z","date":"2025-04-15","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":106.4,"value":266000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":168174,"source":{"system":"sec-edgar","filing":"0001127602-25-012101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225012101/form4.xml","form_type":"4"}},{"id":323914,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-18T20:37:08.000Z","date":"2025-03-17","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":110.53,"value":276325.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":170674,"source":{"system":"sec-edgar","filing":"0001127602-25-009796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009796/form4.xml","form_type":"4"}},{"id":324074,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-03-12T22:41:26.000Z","date":"2025-03-10","kind":"grant","planned":true,"acquired":true,"shares":11090,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":38609,"derivative":{"underlying":"Common Stock","underlying_shares":11090},"source":{"system":"sec-edgar","filing":"0001127602-25-009283","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009283/form4.xml","form_type":"4"}},{"id":324073,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-03-12T22:41:26.000Z","date":"2025-03-10","kind":"grant","planned":true,"acquired":true,"shares":49020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":49020,"derivative":{"exercise_price":117.21,"expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":49020},"source":{"system":"sec-edgar","filing":"0001127602-25-009283","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009283/form4.xml","form_type":"4"}},{"id":324072,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-03-12T22:41:26.000Z","date":"2025-03-10","kind":"exercise","planned":true,"acquired":false,"shares":7968,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":27519,"derivative":{"underlying":"Common Stock","underlying_shares":7968},"source":{"system":"sec-edgar","filing":"0001127602-25-009283","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009283/form4.xml","form_type":"4"}},{"id":324071,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-03-12T22:41:26.000Z","date":"2025-03-10","kind":"exercise","planned":true,"acquired":false,"shares":13013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":63.91,"expiration_date":"2031-03-10","underlying":"Common Stock","underlying_shares":13013},"source":{"system":"sec-edgar","filing":"0001127602-25-009283","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009283/form4.xml","form_type":"4"}},{"id":324070,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-03-12T22:41:26.000Z","date":"2025-03-10","kind":"exercise","planned":true,"acquired":false,"shares":4916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":13013,"derivative":{"exercise_price":63.91,"expiration_date":"2031-03-10","underlying":"Common Stock","underlying_shares":4916},"source":{"system":"sec-edgar","filing":"0001127602-25-009283","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009283/form4.xml","form_type":"4"}},{"id":324069,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-12T22:41:26.000Z","date":"2025-03-10","kind":"tax_withholding","planned":true,"acquired":false,"shares":3855,"price":117.21,"value":451844.55,"ownership":{"direct":true},"balance_after":173174,"source":{"system":"sec-edgar","filing":"0001127602-25-009283","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009283/form4.xml","form_type":"4"}},{"id":324068,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-12T22:41:26.000Z","date":"2025-03-10","kind":"exercise","planned":true,"acquired":true,"shares":7968,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":177029,"source":{"system":"sec-edgar","filing":"0001127602-25-009283","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009283/form4.xml","form_type":"4"}},{"id":324067,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-12T22:41:26.000Z","date":"2025-03-10","kind":"sale","planned":true,"acquired":false,"shares":13013,"price":118.5011,"value":1542054.8143,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $118.00 to $118.80.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":169061,"source":{"system":"sec-edgar","filing":"0001127602-25-009283","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009283/form4.xml","form_type":"4"}},{"id":324066,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-12T22:41:26.000Z","date":"2025-03-10","kind":"sale","planned":true,"acquired":false,"shares":4916,"price":117.2988,"value":576640.9008,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices reported for the transactions reported here range from $116.97 to $117.88.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":182074,"source":{"system":"sec-edgar","filing":"0001127602-25-009283","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009283/form4.xml","form_type":"4"}},{"id":324065,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-12T22:41:26.000Z","date":"2025-03-10","kind":"exercise","planned":true,"acquired":true,"shares":13013,"price":63.91,"value":831660.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":186990,"source":{"system":"sec-edgar","filing":"0001127602-25-009283","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009283/form4.xml","form_type":"4"}},{"id":324064,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-12T22:41:26.000Z","date":"2025-03-10","kind":"exercise","planned":true,"acquired":true,"shares":4916,"price":63.91,"value":314181.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":173977,"source":{"system":"sec-edgar","filing":"0001127602-25-009283","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009283/form4.xml","form_type":"4"}},{"id":325715,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-19T21:43:38.000Z","date":"2025-02-18","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":104.09,"value":260225.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan."}],"balance_after":169061,"source":{"system":"sec-edgar","filing":"0001127602-25-005525","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225005525/form4.xml","form_type":"4"}},{"id":326088,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-02-14T02:13:45.000Z","date":"2025-02-12","kind":"exercise","planned":true,"acquired":false,"shares":18210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":83.49,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":18210},"source":{"system":"sec-edgar","filing":"0001127602-25-004784","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225004784/form4.xml","form_type":"4"}},{"id":326087,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-02-14T02:13:45.000Z","date":"2025-02-12","kind":"exercise","planned":true,"acquired":false,"shares":15600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":80.72,"expiration_date":"2028-03-10","underlying":"Common Stock","underlying_shares":15600},"source":{"system":"sec-edgar","filing":"0001127602-25-004784","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225004784/form4.xml","form_type":"4"}},{"id":326086,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-02-14T02:13:45.000Z","date":"2025-02-12","kind":"exercise","planned":true,"acquired":false,"shares":26175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":78515,"derivative":{"exercise_price":57.92,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":26175},"source":{"system":"sec-edgar","filing":"0001127602-25-004784","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225004784/form4.xml","form_type":"4"}},{"id":326085,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-02-14T02:13:45.000Z","date":"2025-02-12","kind":"exercise","planned":true,"acquired":false,"shares":77691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":17929,"derivative":{"exercise_price":63.91,"expiration_date":"2031-03-10","underlying":"Common Stock","underlying_shares":77691},"source":{"system":"sec-edgar","filing":"0001127602-25-004784","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225004784/form4.xml","form_type":"4"}},{"id":326084,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-14T02:13:45.000Z","date":"2025-02-12","kind":"sale","planned":true,"acquired":false,"shares":137676,"price":102.22,"value":14073240.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":171223,"source":{"system":"sec-edgar","filing":"0001127602-25-004784","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225004784/form4.xml","form_type":"4"}},{"id":326083,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-14T02:13:45.000Z","date":"2025-02-12","kind":"exercise","planned":true,"acquired":true,"shares":18210,"price":83.49,"value":1520352.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":308899,"source":{"system":"sec-edgar","filing":"0001127602-25-004784","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225004784/form4.xml","form_type":"4"}},{"id":326082,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-14T02:13:45.000Z","date":"2025-02-12","kind":"exercise","planned":true,"acquired":true,"shares":15600,"price":80.72,"value":1259232.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":290689,"source":{"system":"sec-edgar","filing":"0001127602-25-004784","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225004784/form4.xml","form_type":"4"}},{"id":326081,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-14T02:13:45.000Z","date":"2025-02-12","kind":"exercise","planned":true,"acquired":true,"shares":26175,"price":57.92,"value":1516056.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":275089,"source":{"system":"sec-edgar","filing":"0001127602-25-004784","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225004784/form4.xml","form_type":"4"}},{"id":326080,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-14T02:13:45.000Z","date":"2025-02-12","kind":"exercise","planned":true,"acquired":true,"shares":77691,"price":63.91,"value":4965231.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":248914,"source":{"system":"sec-edgar","filing":"0001127602-25-004784","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225004784/form4.xml","form_type":"4"}},{"id":326504,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-06T21:11:01.000Z","date":"2025-02-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":43138,"price":97.99,"value":4227092.62,"ownership":{"direct":true},"balance_after":171223,"source":{"system":"sec-edgar","filing":"0001127602-25-003362","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225003362/form4.xml","form_type":"4"}},{"id":326503,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-06T21:11:01.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":64695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on March 10, 2022. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors."}],"balance_after":214361,"source":{"system":"sec-edgar","filing":"0001127602-25-003362","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225003362/form4.xml","form_type":"4"}},{"id":326502,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-06T21:11:01.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":19793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2023 and March 10, 2024. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met."}],"balance_after":149666,"source":{"system":"sec-edgar","filing":"0001127602-25-003362","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225003362/form4.xml","form_type":"4"}},{"id":326766,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-02-03T23:09:25.000Z","date":"2025-01-31","kind":"exercise","planned":true,"acquired":false,"shares":44160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":65.38,"expiration_date":"2029-11-10","underlying":"Common Stock","underlying_shares":44160},"source":{"system":"sec-edgar","filing":"0001127602-25-002821","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225002821/form4.xml","form_type":"4"}},{"id":326765,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-02-03T23:09:25.000Z","date":"2025-01-31","kind":"exercise","planned":true,"acquired":false,"shares":71850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":72.34,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":71850},"source":{"system":"sec-edgar","filing":"0001127602-25-002821","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225002821/form4.xml","form_type":"4"}},{"id":326764,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-02-03T23:09:25.000Z","date":"2025-01-31","kind":"exercise","planned":true,"acquired":false,"shares":26170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":104690,"derivative":{"exercise_price":57.92,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":26170},"source":{"system":"sec-edgar","filing":"0001127602-25-002821","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225002821/form4.xml","form_type":"4"}},{"id":326763,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-03T23:09:25.000Z","date":"2025-01-31","kind":"sale","planned":true,"acquired":false,"shares":142180,"price":97.22,"value":13822739.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sales prices reported for the transactions reported here range from $97.22 to $97.23.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":129873,"source":{"system":"sec-edgar","filing":"0001127602-25-002821","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225002821/form4.xml","form_type":"4"}},{"id":326762,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-03T23:09:25.000Z","date":"2025-01-31","kind":"exercise","planned":true,"acquired":true,"shares":44160,"price":65.38,"value":2887180.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":273053,"source":{"system":"sec-edgar","filing":"0001127602-25-002821","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225002821/form4.xml","form_type":"4"}},{"id":326761,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-03T23:09:25.000Z","date":"2025-01-31","kind":"exercise","planned":true,"acquired":true,"shares":71850,"price":72.34,"value":5197629.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":227893,"source":{"system":"sec-edgar","filing":"0001127602-25-002821","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225002821/form4.xml","form_type":"4"}},{"id":326760,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-03T23:09:25.000Z","date":"2025-01-31","kind":"exercise","planned":true,"acquired":true,"shares":26170,"price":57.92,"value":1515766.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":156043,"source":{"system":"sec-edgar","filing":"0001127602-25-002821","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225002821/form4.xml","form_type":"4"}},{"id":327421,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-16T20:31:12.000Z","date":"2025-01-15","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":91.35,"value":228375.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":129873,"source":{"system":"sec-edgar","filing":"0001127602-25-001321","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225001321/form4.xml","form_type":"4"}},{"id":328257,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-17T22:27:49.000Z","date":"2024-12-16","kind":"sale","planned":true,"acquired":false,"shares":8500,"price":91.96,"value":781660.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":132373,"source":{"system":"sec-edgar","filing":"0001127602-24-029638","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029638/form4.xml","form_type":"4"}},{"id":328479,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-12-12T00:05:28.000Z","date":"2024-12-10","kind":"exercise","planned":false,"acquired":false,"shares":3640,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":35487,"derivative":{"underlying":"Common Stock","underlying_shares":3640},"source":{"system":"sec-edgar","filing":"0001127602-24-029165","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029165/form4.xml","form_type":"4"}},{"id":328478,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-12T00:05:28.000Z","date":"2024-12-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1686,"price":92.34,"value":155685.24,"ownership":{"direct":true},"balance_after":140873,"source":{"system":"sec-edgar","filing":"0001127602-24-029165","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029165/form4.xml","form_type":"4"}},{"id":328477,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-12T00:05:28.000Z","date":"2024-12-10","kind":"exercise","planned":false,"acquired":true,"shares":3640,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":142559,"source":{"system":"sec-edgar","filing":"0001127602-24-029165","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029165/form4.xml","form_type":"4"}},{"id":328750,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-12-03T19:43:20.000Z","date":"2024-11-29","kind":"exercise","planned":true,"acquired":false,"shares":65960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":72.7,"expiration_date":"2026-12-10","underlying":"Common Stock","underlying_shares":65960},"source":{"system":"sec-edgar","filing":"0001127602-24-028397","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028397/form4.xml","form_type":"4"}},{"id":328749,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-12-03T19:43:20.000Z","date":"2024-11-29","kind":"exercise","planned":true,"acquired":false,"shares":43340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option have a three year vesting schedule.  33.33% vest on the first anniversary of the date of the grant.  The balance will vest 8.33% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":72.7,"expiration_date":"2027-08-10","underlying":"Common Stock","underlying_shares":43340},"source":{"system":"sec-edgar","filing":"0001127602-24-028397","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028397/form4.xml","form_type":"4"}},{"id":328748,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-12-03T19:43:20.000Z","date":"2024-11-29","kind":"exercise","planned":true,"acquired":false,"shares":60885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":71.91,"expiration_date":"2028-06-10","underlying":"Common Stock","underlying_shares":60885},"source":{"system":"sec-edgar","filing":"0001127602-24-028397","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028397/form4.xml","form_type":"4"}},{"id":328747,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-12-03T19:43:20.000Z","date":"2024-11-29","kind":"exercise","planned":true,"acquired":false,"shares":33660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":68.75,"expiration_date":"2029-02-06","underlying":"Common Stock","underlying_shares":33660},"source":{"system":"sec-edgar","filing":"0001127602-24-028397","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028397/form4.xml","form_type":"4"}},{"id":328746,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-12-03T19:43:20.000Z","date":"2024-11-29","kind":"exercise","planned":true,"acquired":false,"shares":18630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option have a three year vesting schedule.  33.33% vest on the first anniversary of the date of the grant.  The balance will vest 8.33% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":73.77,"expiration_date":"2027-11-10","underlying":"Common Stock","underlying_shares":18630},"source":{"system":"sec-edgar","filing":"0001127602-24-028397","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028397/form4.xml","form_type":"4"}},{"id":328745,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-12-03T19:43:20.000Z","date":"2024-11-29","kind":"exercise","planned":true,"acquired":false,"shares":26170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":130860,"derivative":{"exercise_price":57.92,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":26170},"source":{"system":"sec-edgar","filing":"0001127602-24-028397","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028397/form4.xml","form_type":"4"}},{"id":328744,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-03T19:43:20.000Z","date":"2024-11-29","kind":"sale","planned":true,"acquired":false,"shares":127930,"price":92.7626,"value":11867119.418,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sales prices reported for the transactions reported here range from $92.33 to $93.09.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":138919,"source":{"system":"sec-edgar","filing":"0001127602-24-028397","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028397/form4.xml","form_type":"4"}},{"id":328743,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-03T19:43:20.000Z","date":"2024-11-29","kind":"sale","planned":true,"acquired":false,"shares":120715,"price":92.7652,"value":11198151.118,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sales prices reported for the transactions reported here range from $92.36 to $93.09.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":266849,"source":{"system":"sec-edgar","filing":"0001127602-24-028397","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028397/form4.xml","form_type":"4"}},{"id":328742,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-03T19:43:20.000Z","date":"2024-11-29","kind":"exercise","planned":true,"acquired":true,"shares":65960,"price":72.7,"value":4795292.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":387564,"source":{"system":"sec-edgar","filing":"0001127602-24-028397","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028397/form4.xml","form_type":"4"}},{"id":328741,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-03T19:43:20.000Z","date":"2024-11-29","kind":"exercise","planned":true,"acquired":true,"shares":43340,"price":72.7,"value":3150818.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":321604,"source":{"system":"sec-edgar","filing":"0001127602-24-028397","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028397/form4.xml","form_type":"4"}},{"id":328740,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-03T19:43:20.000Z","date":"2024-11-29","kind":"exercise","planned":true,"acquired":true,"shares":60885,"price":71.91,"value":4378240.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":278264,"source":{"system":"sec-edgar","filing":"0001127602-24-028397","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028397/form4.xml","form_type":"4"}},{"id":328739,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-03T19:43:20.000Z","date":"2024-11-29","kind":"exercise","planned":true,"acquired":true,"shares":33660,"price":68.75,"value":2314125.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":217379,"source":{"system":"sec-edgar","filing":"0001127602-24-028397","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028397/form4.xml","form_type":"4"}},{"id":328738,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-03T19:43:20.000Z","date":"2024-11-29","kind":"exercise","planned":true,"acquired":true,"shares":26170,"price":57.92,"value":1515766.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":183719,"source":{"system":"sec-edgar","filing":"0001127602-24-028397","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028397/form4.xml","form_type":"4"}},{"id":328737,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-03T19:43:20.000Z","date":"2024-11-29","kind":"exercise","planned":true,"acquired":true,"shares":18630,"price":73.77,"value":1374335.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":157549,"source":{"system":"sec-edgar","filing":"0001127602-24-028397","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028397/form4.xml","form_type":"4"}},{"id":330835,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-09-11T23:20:53.000Z","date":"2024-09-10","kind":"exercise","planned":false,"acquired":false,"shares":3641,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":39127,"derivative":{"underlying":"Common Stock","underlying_shares":3641},"source":{"system":"sec-edgar","filing":"0001127602-24-023815","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224023815/form4.xml","form_type":"4"}},{"id":330834,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-11T23:20:53.000Z","date":"2024-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1682,"price":81.44,"value":136982.08,"ownership":{"direct":true},"balance_after":138919,"source":{"system":"sec-edgar","filing":"0001127602-24-023815","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224023815/form4.xml","form_type":"4"}},{"id":330833,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-11T23:20:53.000Z","date":"2024-09-10","kind":"exercise","planned":false,"acquired":true,"shares":3641,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":140601,"source":{"system":"sec-edgar","filing":"0001127602-24-023815","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224023815/form4.xml","form_type":"4"}},{"id":332902,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-06-11T23:25:27.000Z","date":"2024-06-10","kind":"exercise","planned":false,"acquired":false,"shares":3639,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":42768,"derivative":{"underlying":"Common Stock","underlying_shares":3639},"source":{"system":"sec-edgar","filing":"0001127602-24-018421","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224018421/form4.xml","form_type":"4"}},{"id":332901,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-11T23:25:27.000Z","date":"2024-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1662,"price":65.25,"value":108445.5,"ownership":{"direct":true},"balance_after":136960,"source":{"system":"sec-edgar","filing":"0001127602-24-018421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224018421/form4.xml","form_type":"4"}},{"id":332900,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-11T23:25:27.000Z","date":"2024-06-10","kind":"exercise","planned":false,"acquired":true,"shares":3639,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":138622,"source":{"system":"sec-edgar","filing":"0001127602-24-018421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224018421/form4.xml","form_type":"4"}},{"id":337835,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-03-12T00:59:54.000Z","date":"2024-03-10","kind":"grant","planned":false,"acquired":true,"shares":17305,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":46407,"derivative":{"underlying":"Common Stock","underlying_shares":17305},"source":{"system":"sec-edgar","filing":"0001127602-24-009540","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009540/form4.xml","form_type":"4"}},{"id":337834,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-03-12T00:59:54.000Z","date":"2024-03-10","kind":"grant","planned":false,"acquired":true,"shares":87970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options have a four year vesting schedule. 25% vest on the first anniversary date of the date grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":87970,"derivative":{"exercise_price":75.12,"expiration_date":"2034-03-10","underlying":"Common Stock","underlying_shares":87970},"source":{"system":"sec-edgar","filing":"0001127602-24-009540","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009540/form4.xml","form_type":"4"}}],"next_cursor":"2024-03-12T00:59:54.000000Z,337834"}